Latest Articles

Publication Date
Ayesha Shand, Queen Camilla's Niece, Opens Up About Endometriosis Surgery: 'It's Changed My Life' - SheKnows

Ayesha Shand, Queen Camilla's Niece, Opens Up About Endometriosis Surgery: 'It's Changed My Life' SheKnows

Published: May 10, 2024, 7 a.m.
Emma Barnett: ‘The pain was so bad, I was losing the will to live’ - The Times

Emma Barnett: ‘The pain was so bad, I was losing the will to live’ The Times

Published: May 10, 2024, 7 a.m.
'A step in the right direction': The $49 million win for Australian endometriosis patients - 9Honey

'A step in the right direction': The $49 million win for Australian endometriosis patients 9Honey

Published: May 10, 2024, 7 a.m.
New.com.au's 'About Bloody Time' campaign celebrates $49.1m in federal funding for endometriosis - Mi3

New.com.au's 'About Bloody Time' campaign celebrates $49.1m in federal funding for endometriosis Mi3

Published: May 10, 2024, 7 a.m.
Endometriosis sufferers to get better specialist access under $49 million plan - 9News

Endometriosis sufferers to get better specialist access under $49 million plan 9News

Published: May 10, 2024, 7 a.m.
Endometriosis funding boost ‘great news’ with Medicare to cover longer consultations - Sky News Australia

Endometriosis funding boost ‘great news’ with Medicare to cover longer consultations Sky News Australia

Published: May 10, 2024, 7 a.m.
Living With Endometriosis: a Personal Perspective; a Professional Passion - Yale School of Medicine

Living With Endometriosis: a Personal Perspective; a Professional Passion Yale School of Medicine

Published: May 9, 2024, 7 a.m.
Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer - AJMC.com Managed Markets Network

Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer AJMC.com Managed Markets Network

Published: May 9, 2024, 7 a.m.
Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer - FiercePharma

Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer FiercePharma

Published: May 9, 2024, 7 a.m.
Keytruda Strikes Out Again in Endometrial Cancer with Phase III Flop - BioSpace

Keytruda Strikes Out Again in Endometrial Cancer with Phase III Flop BioSpace

Published: May 9, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!